United States Biotechnology & Medical Research

Vertex Pharmaceuticals Inc (VRTX)

Track

Track

Over the past 90 days, Vertex Pharmaceuticals insiders executed 25 transactions, all involving sales totaling approximately $22.6 million. These divestments, primarily planned, occurred amid a 14% stock price increase. Following a recent earnings report showing a 1.2% EPS beat, executives including the Chief Commercial Officer and CMO reduced their holdings through systematic selling programs.
Ticker: VRTX Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Vertex Pharmaceuticals Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Tatsis Ourania EVP, Chief Reg. & Quality Off. Officer
Transaction date
Planned sale
Price
227.83
Quantity 18,654 +40.1%
Value US$1,108,449
McKechnie Duncan EVP, Chief Commercial Officer Officer
Transaction date
Planned sale
Price
47.60
Quantity 51,512 -33.2%
Value US$3,466,787
Tatsis Ourania Officer Officer
Transaction date
Proposed sale
Price
377.70
Quantity 81,105
Value US$1,534,186
McKechnie Duncan Officer Officer
Transaction date
Proposed sale
Price
519.00
Quantity 1,541
Value US$799,779
Liu Joy EVP and Chief Legal Officer Officer
Transaction date
Planned sale
Price
502.71
Quantity 828 -4.1%
Value US$416,244
Liu Joy Officer Officer
Transaction date
Proposed sale
Price
502.71
Quantity 828
Value US$416,244
Bozic Carmen EVP and CMO Officer
Transaction date
Planned sale
Price
482.50
Quantity 596 -3.7%
Value US$287,570
Bozic Carmen Officer Officer
Transaction date
Proposed sale
Price
482.50
Quantity 596
Value US$287,570
Bozic Carmen EVP and CMO Officer
Transaction date
Planned sale
Price
462.17
Quantity 1,020 -6.0%
Value US$471,413
Bozic Carmen Officer Officer
Transaction date
Proposed sale
Price
462.17
Quantity 1,020
Value US$471,413
Bozic Carmen EVP and CMO Officer
Transaction date
Planned sale
Price
450.00
Quantity 4,062 -19.3%
Value US$1,827,900
Bozic Carmen EVP and CMO Officer
Transaction date
Planned sale
Price
450.00
Quantity 4,062 -19.3%
Value US$1,827,900
Bozic Carmen Officer Officer
Transaction date
Proposed sale
Price
450.00
Quantity 4,062
Value US$1,827,900
Bozic Carmen EVP and CMO Officer
Transaction date
Planned sale
Price
450.00
Quantity 1,745 -7.7%
Value US$785,250
Bozic Carmen Officer Officer
Transaction date
Proposed sale
Price
450.00
Quantity 1,745
Value US$785,250
Liu Joy EVP and Chief Legal Officer Officer
Transaction date
Planned sale
Price
439.91
Quantity 828 -4.0%
Value US$364,245
Liu Joy Officer Officer
Transaction date
Proposed sale
Price
439.91
Quantity 828
Value US$364,245
Bozic Carmen EVP and CMO Officer
Transaction date
Planned sale
Price
450.00
Quantity 1,974 -8.0%
Value US$888,300
Bozic Carmen Officer Officer
Transaction date
Proposed sale
Price
450.00
Quantity 1,974
Value US$888,300
Bozic Carmen EVP and CMO Officer
Transaction date
Planned sale
Price
453.45
Quantity 1,354 -5.2%
Value US$613,971
Bunnage Mark E. EVP, Chief Scientific Officer Officer
Transaction date
Planned sale
Price
453.45
Quantity 33 -0.5%
Value US$14,964
Bozic Carmen Officer Officer
Transaction date
Proposed sale
Price
453.45
Quantity 1,354
Value US$613,971
Bunnage Mark E. Officer Officer
Transaction date
Proposed sale
Price
453.45
Quantity 33
Value US$14,964
Bozic Carmen EVP and CMO Officer
Transaction date
Planned sale
Price
450.00
Quantity 6,988 -21.1%
Value US$3,144,600
Bozic Carmen Officer Officer
Transaction date
Proposed sale
Price
450.00
Quantity 6,988
Value US$3,144,600
Biller Jonathan Officer Officer
Transaction date
Proposed sale
Price
424.25
Quantity 5,193
Value US$2,203,149
Bhatia Sangeeta N. Non-Executive Director
Transaction date
Planned sale
Price
423.73
Quantity 318 -6.1%
Value US$134,746
Bhatia Sangeeta N. Director Non-Executive Director
Transaction date
Proposed sale
Price
423.73
Quantity 318
Value US$134,746
Liu Joy EVP and Chief Legal Officer Officer
Transaction date
Planned sale
Price
425.02
Quantity 1,104 -5.1%
Value US$469,222
Liu Joy Officer Officer
Transaction date
Proposed sale
Price
425.02
Quantity 1,104
Value US$469,222
Liu Joy EVP and Chief Legal Officer Officer
Transaction date
Planned sale
Price
449.17
Quantity 978 -4.3%
Value US$439,288
Liu Joy Officer Officer
Transaction date
Proposed sale
Price
449.17
Quantity 978
Value US$439,288
Bozic Carmen EVP and CMO Officer
Transaction date
Planned sale
Price
450.95
Quantity 2,329 -6.6%
Value US$1,050,263
Bozic Carmen Officer Officer
Transaction date
Proposed sale
Price
450.95
Quantity 2,329
Value US$1,050,263
Bozic Carmen EVP and CMO Officer
Transaction date
Planned sale
Price
481.79
Quantity 2,329 -6.2%
Value US$1,122,089
Bozic Carmen Officer Officer
Transaction date
Proposed sale
Price
481.79
Quantity 2,329
Value US$1,122,089
McKechnie Duncan EVP, Chief Commercial Officer Officer
Transaction date
Planned sale
Price
498.42
Quantity 2,633 -17.4%
Value US$1,312,340
McKechnie Duncan Officer Officer
Transaction date
Proposed sale
Price
498.42
Quantity 2,633
Value US$1,312,340
McKechnie Duncan EVP, Chief Commercial Officer Officer
Transaction date
Planned sale
Price
475.30
Quantity 2,437 -13.9%
Value US$1,158,306
McKechnie Duncan Officer Officer
Transaction date
Proposed sale
Price
475.30
Quantity 2,437
Value US$1,158,306
Liu Joy EVP and Chief Legal Officer Officer
Transaction date
Planned sale
Price
495.96
Quantity 892 -3.8%
Value US$442,396
Liu Joy Officer Officer
Transaction date
Proposed sale
Price
495.96
Quantity 892
Value US$442,396
2.9
Kewalramani Reshma CEO & President Executive Director
Transaction date
Planned sale
Price
496.95
Quantity 1,725 -1.7%
Value US$857,239
2.9
Kewalramani Reshma CEO & President Executive Director
Transaction date
Planned sale
Price
496.16
Quantity 5,995 -5.7%
Value US$2,974,479
2.9
Kewalramani Reshma CEO & President Executive Director
Transaction date
Planned sale
Price
495.38
Quantity 15,580 -12.8%
Value US$7,718,020
2.9
Kewalramani Reshma CEO & President Executive Director
Transaction date
Planned sale
Price
494.33
Quantity 3,498 -2.8%
Value US$1,729,166
2.9
Kewalramani Reshma CEO & President Executive Director
Transaction date
Planned sale
Price
493.29
Quantity 2,520 -2.0%
Value US$1,243,091
2.9
Kewalramani Reshma CEO & President Executive Director
Transaction date
Planned sale
Price
491.30
Quantity 949 -0.7%
Value US$466,244
2.9
Kewalramani Reshma CEO & President Executive Director
Transaction date
Planned sale
Price
490.54
Quantity 2,725 -2.1%
Value US$1,336,722
2.9
Kewalramani Reshma CEO & President Executive Director
Transaction date
Planned sale
Price
489.32
Quantity 460 -0.3%
Value US$225,087
2.9
Kewalramani Reshma CEO & President Executive Director
Transaction date
Planned sale
Price
488.27
Quantity 3,278 -2.4%
Value US$1,600,549
2.9
Kewalramani Reshma CEO & President Executive Director
Transaction date
Planned sale
Price
487.13
Quantity 2,510 -1.8%
Value US$1,222,696
2.9
Kewalramani Reshma CEO & President Executive Director
Transaction date
Planned sale
Price
482.84
Quantity 240 -0.2%
Value US$115,882
2.9
Kewalramani Reshma CEO & President Executive Director
Transaction date
Planned sale
Price
481.50
Quantity 120 -0.1%
Value US$57,780
2.9
Kewalramani Reshma CEO & President Executive Director
Transaction date
Planned sale
Price
479.75
Quantity 400 -0.3%
Value US$191,900
Bozic Carmen EVP and CMO Officer
Transaction date
Planned sale
Price
480.31
Quantity 2,329 -5.8%
Value US$1,118,642
2.9
Kewalramani Reshma Officer; Director Executive Director
Transaction date
Proposed sale
Price
493.47
Quantity 40,000
Value US$19,738,905
Bozic Carmen Officer Officer
Transaction date
Proposed sale
Price
480.31
Quantity 2,329
Value US$1,118,642
Ambrose Kristen SVP & Chief Accounting Officer Officer
Transaction date
Planned sale
Price
483.36
Quantity 357 -5.1%
Value US$172,560
Tatsis Ourania EVP, Chief Reg. & Quality Off. Officer
Transaction date
Planned sale
Price
486.35
Quantity 260 -0.6%
Value US$126,451
Sachdev Amit EVP Chief Patient & Ext Af Off Officer
Transaction date
Planned sale
Price
486.35
Quantity 1,846 -3.2%
Value US$897,802
McKechnie Duncan EVP, Chief Commercial Officer Officer
Transaction date
Planned sale
Price
489.00
Quantity 2,410 -12.1%
Value US$1,178,490
McKechnie Duncan EVP, Chief Commercial Officer Officer
Transaction date
Planned sale
Price
486.35
Quantity 2,500 -11.1%
Value US$1,215,875
Bunnage Mark E. EVP, Chief Scientific Officer Officer
Transaction date
Planned sale
Price
486.35
Quantity 620 -7.8%
Value US$301,537
Biller Jonathan EVP and Chief Legal Officer Officer
Transaction date
Planned sale
Price
486.35
Quantity 945 -6.5%
Value US$459,601
Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. Officer
Transaction date
Planned sale
Price
486.35
Quantity 668 -3.5%
Value US$324,882
Ambrose Kristen SVP & Chief Accounting Officer Officer
Transaction date
Planned sale
Price
486.35
Quantity 223 -3.1%
Value US$108,456
McKechnie Duncan Officer Officer
Transaction date
Proposed sale
Price
487.65
Quantity 4,910
Value US$2,394,365
Tatsis Ourania Officer Officer
Transaction date
Proposed sale
Price
486.35
Quantity 260
Value US$126,451
Bunnage Mark E. Officer Officer
Transaction date
Proposed sale
Price
486.35
Quantity 620
Value US$301,537
Atkinson Edward Morrow III Officer Officer
Transaction date
Proposed sale
Price
486.35
Quantity 668
Value US$324,882
Sachdev Amit Officer Officer
Transaction date
Proposed sale
Price
486.35
Quantity 1,846
Value US$897,802
Biller Jonathan Officer Officer
Transaction date
Proposed sale
Price
486.35
Quantity 945
Value US$459,601
Sachdev Amit EVP Chief Patient & Ext Af Off Officer
Transaction date
Planned sale
Price
471.43
Quantity 4,237 -6.7%
Value US$1,997,449
Sachdev Amit EVP Chief Patient & Ext Af Off Officer
Transaction date
Planned sale
Price
470.54
Quantity 11,712 -15.6%
Value US$5,510,964
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-07 2026-07-02 PlS Planned sale
Tatsis Ourania

EVP, Chief Reg. & Quality Off.

Officer
18,654 +40.1%
227.83
US$1,108,449 		18,654 +40.1% 227.83 US$1,108,449
2026-07-07 2026-07-02 PlS Planned sale
McKechnie Duncan

EVP, Chief Commercial Officer

Officer
51,512 -33.2%
47.60
US$3,466,787 		51,512 -33.2% 47.60 US$3,466,787
2026-07-02 2026-07-02 PrS Proposed sale
Tatsis Ourania

Officer

Officer
81,105
377.70
US$1,534,186 		81,105 377.70 US$1,534,186
2026-07-02 2026-07-02 PrS Proposed sale
McKechnie Duncan

Officer

Officer
1,541
519.00
US$799,779 		1,541 519.00 US$799,779
2026-07-06 2026-07-01 PlS Planned sale
Liu Joy

EVP and Chief Legal Officer

Officer
828 -4.1%
502.71
US$416,244 		828 -4.1% 502.71 US$416,244
2026-07-01 2026-07-01 PrS Proposed sale
Liu Joy

Officer

Officer
828
502.71
US$416,244 		828 502.71 US$416,244
2026-06-30 2026-06-26 PlS Planned sale
Bozic Carmen

EVP and CMO

Officer
596 -3.7%
482.50
US$287,570 		596 -3.7% 482.50 US$287,570
2026-06-26 2026-06-26 PrS Proposed sale
Bozic Carmen

Officer

Officer
596
482.50
US$287,570 		596 482.50 US$287,570
2026-06-23 2026-06-18 PlS Planned sale
Bozic Carmen

EVP and CMO

Officer
1,020 -6.0%
462.17
US$471,413 		1,020 -6.0% 462.17 US$471,413
2026-06-18 2026-06-18 PrS Proposed sale
Bozic Carmen

Officer

Officer
1,020
462.17
US$471,413 		1,020 462.17 US$471,413
2026-06-17 2026-06-15 PlS Planned sale
Bozic Carmen

EVP and CMO

Officer
4,062 -19.3%
450.00
US$1,827,900 		4,062 -19.3% 450.00 US$1,827,900
2026-06-17 2026-06-15 PlS Planned sale
Bozic Carmen

EVP and CMO

Officer
4,062 -19.3%
450.00
US$1,827,900 		4,062 -19.3% 450.00 US$1,827,900
2026-06-15 2026-06-15 PrS Proposed sale
Bozic Carmen

Officer

Officer
4,062
450.00
US$1,827,900 		4,062 450.00 US$1,827,900
2026-06-09 2026-06-05 PlS Planned sale
Bozic Carmen

EVP and CMO

Officer
1,745 -7.7%
450.00
US$785,250 		1,745 -7.7% 450.00 US$785,250
2026-06-05 2026-06-05 PrS Proposed sale
Bozic Carmen

Officer

Officer
1,745
450.00
US$785,250 		1,745 450.00 US$785,250
2026-06-03 2026-06-01 PlS Planned sale
Liu Joy

EVP and Chief Legal Officer

Officer
828 -4.0%
439.91
US$364,245 		828 -4.0% 439.91 US$364,245
2026-06-01 2026-06-01 PrS Proposed sale
Liu Joy

Officer

Officer
828
439.91
US$364,245 		828 439.91 US$364,245
2026-06-02 2026-05-29 PlS Planned sale
Bozic Carmen

EVP and CMO

Officer
1,974 -8.0%
450.00
US$888,300 		1,974 -8.0% 450.00 US$888,300
2026-05-29 2026-05-29 PrS Proposed sale
Bozic Carmen

Officer

Officer
1,974
450.00
US$888,300 		1,974 450.00 US$888,300
2026-05-19 2026-05-15 PlS Planned sale
Bozic Carmen

EVP and CMO

Officer
1,354 -5.2%
453.45
US$613,971 		1,354 -5.2% 453.45 US$613,971
2026-05-19 2026-05-15 PlS Planned sale
Bunnage Mark E.

EVP, Chief Scientific Officer

Officer
33 -0.5%
453.45
US$14,964 		33 -0.5% 453.45 US$14,964
2026-05-15 2026-05-15 PrS Proposed sale
Bozic Carmen

Officer

Officer
1,354
453.45
US$613,971 		1,354 453.45 US$613,971
2026-05-15 2026-05-15 PrS Proposed sale
Bunnage Mark E.

Officer

Officer
33
453.45
US$14,964 		33 453.45 US$14,964
2026-05-14 2026-05-12 PlS Planned sale
Bozic Carmen

EVP and CMO

Officer
6,988 -21.1%
450.00
US$3,144,600 		6,988 -21.1% 450.00 US$3,144,600
2026-05-12 2026-05-12 PrS Proposed sale
Bozic Carmen

Officer

Officer
6,988
450.00
US$3,144,600 		6,988 450.00 US$3,144,600
2026-05-06 2026-05-06 PrS Proposed sale
Biller Jonathan

Officer

Officer
5,193
424.25
US$2,203,149 		5,193 424.25 US$2,203,149
2026-05-05 2026-05-04 PlS Planned sale
Bhatia Sangeeta N.
Non-Executive Director
318 -6.1%
423.73
US$134,746 		318 -6.1% 423.73 US$134,746
2026-05-04 2026-05-04 PrS Proposed sale
Bhatia Sangeeta N.

Director

Non-Executive Director
318
423.73
US$134,746 		318 423.73 US$134,746
2026-05-05 2026-05-01 PlS Planned sale
Liu Joy

EVP and Chief Legal Officer

Officer
1,104 -5.1%
425.02
US$469,222 		1,104 -5.1% 425.02 US$469,222
2026-05-01 2026-05-01 PrS Proposed sale
Liu Joy

Officer

Officer
1,104
425.02
US$469,222 		1,104 425.02 US$469,222
2026-04-03 2026-04-01 PlS Planned sale
Liu Joy

EVP and Chief Legal Officer

Officer
978 -4.3%
449.17
US$439,288 		978 -4.3% 449.17 US$439,288
2026-04-01 2026-04-01 PrS Proposed sale
Liu Joy

Officer

Officer
978
449.17
US$439,288 		978 449.17 US$439,288
2026-03-31 2026-03-27 PlS Planned sale
Bozic Carmen

EVP and CMO

Officer
2,329 -6.6%
450.95
US$1,050,263 		2,329 -6.6% 450.95 US$1,050,263
2026-03-27 2026-03-27 PrS Proposed sale
Bozic Carmen

Officer

Officer
2,329
450.95
US$1,050,263 		2,329 450.95 US$1,050,263
2026-03-17 2026-03-13 PlS Planned sale
Bozic Carmen

EVP and CMO

Officer
2,329 -6.2%
481.79
US$1,122,089 		2,329 -6.2% 481.79 US$1,122,089
2026-03-13 2026-03-13 PrS Proposed sale
Bozic Carmen

Officer

Officer
2,329
481.79
US$1,122,089 		2,329 481.79 US$1,122,089
2026-03-13 2026-03-11 PlS Planned sale
McKechnie Duncan

EVP, Chief Commercial Officer

Officer
2,633 -17.4%
498.42
US$1,312,340 		2,633 -17.4% 498.42 US$1,312,340
2026-03-11 2026-03-11 PrS Proposed sale
McKechnie Duncan

Officer

Officer
2,633
498.42
US$1,312,340 		2,633 498.42 US$1,312,340
2026-03-06 2026-03-04 PlS Planned sale
McKechnie Duncan

EVP, Chief Commercial Officer

Officer
2,437 -13.9%
475.30
US$1,158,306 		2,437 -13.9% 475.30 US$1,158,306
2026-03-04 2026-03-04 PrS Proposed sale
McKechnie Duncan

Officer

Officer
2,437
475.30
US$1,158,306 		2,437 475.30 US$1,158,306
2026-03-04 2026-03-02 PlS Planned sale
Liu Joy

EVP and Chief Legal Officer

Officer
892 -3.8%
495.96
US$442,396 		892 -3.8% 495.96 US$442,396
2026-03-02 2026-03-02 PrS Proposed sale
Liu Joy

Officer

Officer
892
495.96
US$442,396 		892 495.96 US$442,396
2026-03-03 2026-02-27 PlS Planned sale
2.9
Kewalramani Reshma

CEO & President

Executive Director
1,725 -1.7%
496.95
US$857,239 		1,725 -1.7% 496.95 US$857,239
2026-03-03 2026-02-27 PlS Planned sale
2.9
Kewalramani Reshma

CEO & President

Executive Director
5,995 -5.7%
496.16
US$2,974,479 		5,995 -5.7% 496.16 US$2,974,479
2026-03-03 2026-02-27 PlS Planned sale
2.9
Kewalramani Reshma

CEO & President

Executive Director
15,580 -12.8%
495.38
US$7,718,020 		15,580 -12.8% 495.38 US$7,718,020
2026-03-03 2026-02-27 PlS Planned sale
2.9
Kewalramani Reshma

CEO & President

Executive Director
3,498 -2.8%
494.33
US$1,729,166 		3,498 -2.8% 494.33 US$1,729,166
2026-03-03 2026-02-27 PlS Planned sale
2.9
Kewalramani Reshma

CEO & President

Executive Director
2,520 -2.0%
493.29
US$1,243,091 		2,520 -2.0% 493.29 US$1,243,091
2026-03-03 2026-02-27 PlS Planned sale
2.9
Kewalramani Reshma

CEO & President

Executive Director
949 -0.7%
491.30
US$466,244 		949 -0.7% 491.30 US$466,244
2026-03-03 2026-02-27 PlS Planned sale
2.9
Kewalramani Reshma

CEO & President

Executive Director
2,725 -2.1%
490.54
US$1,336,722 		2,725 -2.1% 490.54 US$1,336,722
2026-03-03 2026-02-27 PlS Planned sale
2.9
Kewalramani Reshma

CEO & President

Executive Director
460 -0.3%
489.32
US$225,087 		460 -0.3% 489.32 US$225,087
2026-03-03 2026-02-27 PlS Planned sale
2.9
Kewalramani Reshma

CEO & President

Executive Director
3,278 -2.4%
488.27
US$1,600,549 		3,278 -2.4% 488.27 US$1,600,549
2026-03-03 2026-02-27 PlS Planned sale
2.9
Kewalramani Reshma

CEO & President

Executive Director
2,510 -1.8%
487.13
US$1,222,696 		2,510 -1.8% 487.13 US$1,222,696
2026-03-03 2026-02-27 PlS Planned sale
2.9
Kewalramani Reshma

CEO & President

Executive Director
240 -0.2%
482.84
US$115,882 		240 -0.2% 482.84 US$115,882
2026-03-03 2026-02-27 PlS Planned sale
2.9
Kewalramani Reshma

CEO & President

Executive Director
120 -0.1%
481.50
US$57,780 		120 -0.1% 481.50 US$57,780
2026-03-03 2026-02-27 PlS Planned sale
2.9
Kewalramani Reshma

CEO & President

Executive Director
400 -0.3%
479.75
US$191,900 		400 -0.3% 479.75 US$191,900
2026-03-03 2026-02-27 PlS Planned sale
Bozic Carmen

EVP and CMO

Officer
2,329 -5.8%
480.31
US$1,118,642 		2,329 -5.8% 480.31 US$1,118,642
2026-02-27 2026-02-27 PrS Proposed sale
2.9
Kewalramani Reshma

Officer; Director

Executive Director
40,000
493.47
US$19,738,905 		40,000 493.47 US$19,738,905
2026-02-27 2026-02-27 PrS Proposed sale
Bozic Carmen

Officer

Officer
2,329
480.31
US$1,118,642 		2,329 480.31 US$1,118,642
2026-03-02 2026-02-26 PlS Planned sale
Ambrose Kristen

SVP & Chief Accounting Officer

Officer
357 -5.1%
483.36
US$172,560 		357 -5.1% 483.36 US$172,560
2026-02-26 2026-02-25 PlS Planned sale
Tatsis Ourania

EVP, Chief Reg. & Quality Off.

Officer
260 -0.6%
486.35
US$126,451 		260 -0.6% 486.35 US$126,451
2026-02-26 2026-02-25 PlS Planned sale
Sachdev Amit

EVP Chief Patient & Ext Af Off

Officer
1,846 -3.2%
486.35
US$897,802 		1,846 -3.2% 486.35 US$897,802
2026-02-26 2026-02-25 PlS Planned sale
McKechnie Duncan

EVP, Chief Commercial Officer

Officer
2,410 -12.1%
489.00
US$1,178,490 		2,410 -12.1% 489.00 US$1,178,490
2026-02-26 2026-02-25 PlS Planned sale
McKechnie Duncan

EVP, Chief Commercial Officer

Officer
2,500 -11.1%
486.35
US$1,215,875 		2,500 -11.1% 486.35 US$1,215,875
2026-02-26 2026-02-25 PlS Planned sale
Bunnage Mark E.

EVP, Chief Scientific Officer

Officer
620 -7.8%
486.35
US$301,537 		620 -7.8% 486.35 US$301,537
2026-02-26 2026-02-25 PlS Planned sale
Biller Jonathan

EVP and Chief Legal Officer

Officer
945 -6.5%
486.35
US$459,601 		945 -6.5% 486.35 US$459,601
2026-02-26 2026-02-25 PlS Planned sale
Atkinson Edward Morrow III

EVP, Chief Technical Ops. Off.

Officer
668 -3.5%
486.35
US$324,882 		668 -3.5% 486.35 US$324,882
2026-02-26 2026-02-25 PlS Planned sale
Ambrose Kristen

SVP & Chief Accounting Officer

Officer
223 -3.1%
486.35
US$108,456 		223 -3.1% 486.35 US$108,456
2026-02-25 2026-02-25 PrS Proposed sale
McKechnie Duncan

Officer

Officer
4,910
487.65
US$2,394,365 		4,910 487.65 US$2,394,365
2026-02-25 2026-02-25 PrS Proposed sale
Tatsis Ourania

Officer

Officer
260
486.35
US$126,451 		260 486.35 US$126,451
2026-02-25 2026-02-25 PrS Proposed sale
Bunnage Mark E.

Officer

Officer
620
486.35
US$301,537 		620 486.35 US$301,537
2026-02-25 2026-02-25 PrS Proposed sale
Atkinson Edward Morrow III

Officer

Officer
668
486.35
US$324,882 		668 486.35 US$324,882
2026-02-25 2026-02-25 PrS Proposed sale
Sachdev Amit

Officer

Officer
1,846
486.35
US$897,802 		1,846 486.35 US$897,802
2026-02-25 2026-02-25 PrS Proposed sale
Biller Jonathan

Officer

Officer
945
486.35
US$459,601 		945 486.35 US$459,601
2026-02-23 2026-02-19 PlS Planned sale
Sachdev Amit

EVP Chief Patient & Ext Af Off

Officer
4,237 -6.7%
471.43
US$1,997,449 		4,237 -6.7% 471.43 US$1,997,449
2026-02-23 2026-02-19 PlS Planned sale
Sachdev Amit

EVP Chief Patient & Ext Af Off

Officer
11,712 -15.6%
470.54
US$5,510,964 		11,712 -15.6% 470.54 US$5,510,964
Explore more

More insider trading research around Vertex Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America
Insider trades in S&P 500